Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-(3-Chlorophenyl)-3-oxopropanenitrile → 4-chloro-3-(3-chlorophenyl)-1-methyl-5-phenyl-1H-pyrazolo[3,4-c]pyridazine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-(3-Chlorophenyl)-3-oxopropanenitrile | HCID 140855 | — |
| 반응물 | 4-chloro-3-(2-chlorophenyl)-1-methyl-5-phenyl-1H-pyrazolo[3,4-c]pyridazine | HCID 66576482 | — |
| 생성물 | 4-chloro-3-(3-chlorophenyl)-1-methyl-5-phenyl-1H-pyrazolo[3,4-c]pyridazine | HCID 66576558 | — |
반응 단계
Compound 13 was synthesised following similar procedures outlined in Example 1 (Compound 37), using 3-chlorobenzoylacetonitrile instead of 2-chlorobenzoyl acetonitrile in Step 1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09260381B2 |
| 출처 데이터셋 | uspto-grants-2016_02 |
| ORD ID | ord-d4ac013b68b7420da8450309614bcf93 |
| 출처 메모 | uspto-grants-2016_02 |